Neil Dey's Insider Trades & SAST Disclosures
Neil Dey's most recent trade in Bluejay Diagnostics Inc was a trade of 500 Common Stock done at an average price of $3.3 . Disclosure was reported to the exchange on Dec. 13, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Neil Dey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bluejay Diagnostics Inc | Dey Neil | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.27 per share. | 13 Dec 2023 | 500 | 28,526 | - | 3.3 | 1,635 | Common Stock |
| Bluejay Diagnostics Inc | Neil Dey | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.44 per share. | 27 Mar 2023 | 8,000 | 558,538 | - | 0.4 | 3,520 | Common Stock |
| Bluejay Diagnostics Inc | Neil Dey | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.44 per share. | 27 Mar 2023 | 2,000 | 660,538 | - | 0.4 | 880 | Common Stock |
| Bluejay Diagnostics Inc | Neil Dey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.44 per share. | 01 Feb 2023 | 159,090 | 606,150 | - | 0.4 | 70,000 | Common Stock |
| Bluejay Diagnostics Inc | Neil Dey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. | 01 Feb 2023 | 55,612 | 550,538 | - | 0.4 | 24,469 | Common Stock |
| Bluejay Diagnostics Inc | Neil Dey | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 14,116 | 15,848 | - | - | Option to purchase common stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges